In this study, LD4-PDT treatment significantly inhibited TNF-α, IL-1 and IL-6 expression, and consequently reduced the severity of colitis in UC model (Huang et al., 2017; Lee et al., 2020; Li et al., 2020). This evidence concerns the gene IL1B and colitis.